21 Jan, 16 | by BMJ
“Thirdly, we will post the protocol of our trials as they are started and the results of trials once they are completed on two websites which are available to the public, clinicaltrials.gov and roche-trials.com.”
Such a policy would place the Swiss pharmaceutical company ahead of its peers, even GlaxoSmithKline, generally seen as the pharma leader in trial transparency.
The only problem is that does not appear to be true. more…